Effects of sex, age and BMI on screening tests for impaired glucose tolerance
Introduction
The increase in type 2 diabetes mellitus is a major health problem worldwide. It has been estimated that worldwide the number of patients with diabetes will be more than double by the year 2025 [1], and in Japan the number will increase from approximately 6.9 million in 1997 to 10.8 million in 2010 [2].
In Japan, the prevalence of impaired glucose tolerance (IGT) is two to three times that of diabetes mellitus [3]. The higher prevalence of IGT may suggest that patients with diabetes will increase in the future with the change in lifestyle. Actually, it is well known that Japanese immigrants in the US have a higher prevalence of diabetes mellitus than Japanese in Japan [4], [5]. Their lifestyle is more western than Japanese natives despite the same genetic backgrounds. Furthermore, subjects with IGT are at a substantial risk of developing cardiovascular diseases [6]. Japanese community-based cohort studies observed that death from cardiovascular diseases was approximately twice that of people with normal glucose tolerance [7], [8].
IGT can be recognized as a sub-clinical state needing intervention from a public health point of view. Recently, the final reports of primary prevention trials of type 2 diabetes mellitus that targeted subjects with IGT were published in succession [9], [10], [11]. One of the reviews about prevention of diabetes mellitus from these results has regarded subjects with IGT as potential candidates for intervention [12]. Diagnosis of IGT requires oral glucose tolerance test (OGTT). It is inefficient to perform OGTT on numerous people, so various methods were proposed to reduce the number of OGTT for screening of IGT [13], [14]. However, the appropriate method has not been established and the available information about screening for IGT is limited.
In the present study, we evaluated the discriminating abilities of fasting plasma glucose (FPG) and HbA1c by the receiver operating characteristic (ROC) curve analysis [15] for screening of IGT and then examined effects of sex, age and BMI on the screening performance.
Section snippets
Study population
We enrolled 997 subjects (461 males and 536 females, aged 30–59 years, without a previous history of diabetes), who were recruited for OGTT after the first screening of the Japan Diabetes Prevention Program (JDPP). JDPP is a randomized clinical trial designed to assess the efficacy of intensive diet and exercise to prevent or delay the onset of type 2 diabetes mellitus in subjects with IGT. This trial started in April 1999 in collaboration with 27 centers in communities in various districts
Results
The characteristics of the study subjects by glucose tolerance are shown in Table 1. According to the 1997 criteria of ADA, 140 subjects were classified as diabetes (14.0%), 256 as having IGT (25.7%), 87 as having IFG (8.7%) and 514 as having NGT (51.6%). One-way analysis of variance was significant for all variables including age (P<0.0001).
Fig. 1 shows ROC curves of FPG and HbA1c for screening of IGT. Both curves lie above the diagonal line, which means both tests can discriminate between
Discussion
The present results allow some considerations about the proposed screening for IGT.
First, this study showed that the discriminating ability of FPG was superior to that of HbA1c, although each test can discriminate between IGT and non-IGT (NGT plus IFG). This is not due to the difference of CVs between the two parameters because CVs of the both were not so different. Although it is widely accepted that FPG is recommendable as a screening variable for diabetes mellitus [20], it is not always so
Acknowledgements
This study was supported by a Grant for Research on Health Services from the Ministry of Health, Labour and Welfare, Japan. Authors are indebted to the collaborative centers in various districts in Japan.
References (30)
- et al.
The high prevalence of diabetes mellitus and hyperinsulinemia among the Japanese-Americans living in Hawaii and Los Angeles
Diab. Res. Clin. Pract.
(1994) - et al.
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Lancet
(2002) - et al.
Association between glycated hemoglobin and diet and other lifestyle factors in a nondiabetic population: cross-sectional evaluation of data from the Potsdam cohort of the European Prospective Investigation into Cancer and Nutrition Study
Am. J. Clin. Nutr.
(2000) - et al.
Acceleration of hemoglobin glycation with aging
Clin. Chim. Acta
(1993) - et al.
Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections
Diab. Care
(1998) Survey of diabetes mellitus by Ministry of Health and Welfare in 1997
Endocrinol. Diabetol.
(2002)- et al.
Comparison of the prevalence of diabetes mellitus and impaired glucose tolerance in Japan and other countries
J. Jpn. Diab. Soc.
(1998) - et al.
Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men
Diabetes
(1987) - et al.
Asymptomatic hyperglycaemia is associated with increased intimal plus medial thickness of the carotid artery
Diabetologia
(1995) - et al.
Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study
Diabetes
(1996)